RETINAL WHITE DOTS SYNDROME

RETINAL WHITE DOTS SYNDROME was reported 26 times

RETINAL WHITE DOTS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 1 0.0005
1 Iron Chelator [EPC] 4 0.0001
2 Glycopeptide Antibacterial [EPC] 8 0.0001
3 Chloride Channel Activator [EPC] 1 0.0001
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 1 0.0001
5 Antimalarial [EPC] 1 0.0001
6 Antiprotozoal [EPC] 1 0.0001
7 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
8 Tetracycline-class Drug [EPC] 5 0.0001
9 Calcium [EPC] 7 0.0000
10 Progesterone [EPC] 1 0.0000
11 Vascular Endothelial Growth Factor Inhibitor [EPC] 7 0.0000
12 Ester Local Anesthetic [EPC] 1 0.0000
13 Macrolide Antimicrobial [EPC] 1 0.0000
14 Folate Analog Metabolic Inhibitor [EPC] 7 0.0000
15 Atypical Antipsychotic [EPC] 7 0.0000
16 Nitroimidazole Antimicrobial [EPC] 1 0.0000
17 Non-Standardized Chemical Allergen [EPC] 1 0.0000
18 Amide Local Anesthetic [EPC] 1 0.0000
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
20 Antiarrhythmic [EPC] 1 0.0000
21 Aminosalicylate [EPC] 1 0.0000
22 5-alpha Reductase Inhibitor [EPC] 1 0.0000
23 Interleukin-23 Antagonist [EPC] 1 0.0000
24 Corticosteroid [EPC] 10 0.0000
25 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
26 alpha-Adrenergic Blocker [EPC] 1 0.0000
27 Estrogen [EPC] 1 0.0000
28 Platinum-based Drug [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 2 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
31 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000
32 Benzodiazepine [EPC] 1 0.0000